Merlin/NF2SuppressesTumorigenesisbyInhibitingtheE3UbiquitinLigaseCRL4DCAF1intheNucleusWeiLi,1,8LiruYou,1,8JonathanCooper,1,4GaiaSchiavon,1AngelaPepe-Caprio,1LuZhou,5RyoheiIshii,6MarcoGiovannini,7C.OliverHanemann,5StephenB.Long,2HediyeErdjument-Bromage,3PengboZhou,6PaulTempst,3andFilippoG.Giancotti1,*1CellBiologyProgram2StructuralBiologyProgram3MolecularBiologyProgramMemorialSloan-KetteringCancerCenter,NewYork,NY10065,USA4Sloan-KetteringDivision,WeillGraduateSchoolofMedicalSciences,CornellUniversity,NewYork,NY10065,USA5PeninsulaCollegeofMedicineandDentistry,UniversityofPlymouth,PlymouthPL68BU,UK6DepartmentofPathologyandLaboratoryMedicine,WeilCornellMedicalCollege,NewYork,NY10065,USA7HouseEarInstitute,CenterforNeuralTumorResearch,LosAngeles,CA90057,USA8Theseauthorscontributedequallytothiswork*Correspondence:f-giancotti@ski.mskcc.orgDOI10.1016/j.cell.2010.01.029SUMMARYCurrentmodelsimplythattheFERMdomainproteinMerlin,encodedbythetumorsuppressorNF2,inhibitsmitogenicsignalingatorneartheplasmamembrane.Here,weshowthattheclosed,growth-inhibitoryformofMerlinaccumulatesinthenucleus,bindstotheE3ubiquitinligaseCRL4DCAF1,andsuppressesitsactivity.DepletionofDCAF1blocksthepromitogeniceffectofinactivationofMerlin.Conversely,enforcedexpressionofaMerlin-insensi-tivemutantofDCAF1counteractstheantimitogeniceffectofMerlin.Re-expressionofMerlinandsilencingofDCAF1implementasimilar,tumor-suppressiveprogramofgeneexpression.Tumor-derivedmutationsinvariablydisruptMerlin’sabilitytointeractwithorinhibitCRL4DCAF1.Finally,deple-tionofDCAF1inhibitsthehyperproliferationofSchwannomacellsfromNF2patientsandsuppressestheoncogenicpotentialofMerlin-deﬁ-cienttumorcelllines.WeproposethatMerlinsuppressestumorigenesisbytranslocatingtothenucleustoinhibitCRL4DCAF1.INTRODUCTIONThetumorsuppressorNF2,whichisinactivatedinthefamilialcancersyndromeNeuroﬁbromatosistype2,encodesforMerlin,amemberoftheEzrin/Radixin/Moesin(ERM)familyofproteins.TheprevalenceofNF2mutationsinsporadictumors,especiallySchwannomas,meningiomas,andmalignantmesotheliomas,andthepredispositionofheterozygousNf2mutantmicetodevelopmultiplemalignanttumortypessuggestthatMerlinhasarelativelybroadtumor-suppressorfunction(McClatcheyandGiovannini,2005;Okadaetal.,2007).DespiteextensiveresearchonMerlin’sroleasatumorsuppressor,itsbiologicalfunctionremainspoorlyunderstood.ClassicalERMproteins,whichconsistofanN-terminalFERMdomain,acoiled-coildomain,andaC-terminalsegmentcon-taininganactin-bindingmotif,switchbetweenaclosedconfor-mation,presumeddormant,andanopenconformation,whichmediateslinkageofcertaincelladhesionreceptorstotheactincytoskeleton(Bretscheretal.,2002).ThesequencehomologyofMerlintoERMproteinsanditsapparentlyprevalentlocaliza-tiontothecorticalcytoskeletonhaveledtothehypothesisthatMerlinfunctionsatorneartheplasmamembranetoinhibitthetransmissionofpromitogenicsignals(McClatcheyandFehon,2009).However,Merlindoesnotcontainacanonicalactin-bindingmotif.Inaddition,itistheclosedformofMerlinthatsuppressestumorigenesisandistherebyconsidered‘‘active.’’Infact,manytumor-derivedmissensemutationsarepredictedtodisrupttheclosedconformation(Okadaetal.,2007).TheinterconversionbetweentheclosedandtheopenformofMerlinispromotedbythep21-activatedkinasePAK,whichphosphorylatesMerlinatS518,disruptingtheintramolecularC-terminaltail-FERMinteraction,whichmaintainstheproteinintheclosedconformation(Kissiletal.,2002;Xiaoetal.,2002).Cadherin-mediatedadhesioninhibitsPAK,causinganaccumu-lationofthedephosphorylated,growth-inhibitoryformofMerlin.Conversely,integrin-dependentadhesiontothematrixactivatesPAK,causinginactivationofMerlinand,thereby,presumablyremovingablocktocell-cycleprogression(Okadaetal.,2005).Accordingly,inactivationofMerlininducesexitfromcontactinhibition(Lallemandetal.,2003;Lallemandetal.,2009;Okadaetal.,2005)andacceleratesprogressionthroughtheG1phaseofthecellcycle(Lo´pez-Lagoetal.,2009).TheseresultssuggestCell140,477–490,February19,2010ª2010ElsevierInc.477Figure1.MerlinAssociateswithCRL4DCAF1intheNucleus(A)Cos7cellsweretransfectedwiththeindicatedFH-tagged(FH;FLAG-HA)formsofMerlin,lysedinRIPA,andsubjectedtoTAP.ProteinswereseparatedbySDS-PAGEandstainedwithColloidalBlue.DotspointtotheFH-taggedbaitsandasteriskstothe169and127kDbandsidentiﬁedbymassspectrometryasDCAF1andDDB1,respectively.(B)293TcellsweretransfectedwithFH-DCAF1oremptyvector.TotallysatesandFlagimmunoprecipitates(M2)weresubjectedtoimmunoblottingwithanti-bodiestotheindicatedproteins.(C)Asin(B),withtransfectionoftheindicatedconstructsandimmunoprecipitationwithanti-FLAG(M2)orcontrol(C)antibodies.(D)Asin(B),withcotransfectionofMyc-Merlinoremptyvectorandimmunoprecipitationwithanti-FLAG(M2)orcontrol(C).Tocontrolforthespeciﬁcityoftheanti-P-Merlinantibodies,theindicatedsamplewastreatedwithcalfintestinalalkalinephosphatase(CIP)priortoSDS-PAGE.EndogenousMerlinwasdetecteduponlongerexposure.(E)Meso-33cellsweretransientlytransfectedwiththeindicatedconstructsandsubjectedtodouble-immunoﬂuorescentstainingwithanti-HAandanti-Mycfol-lowedbyDAPI.(F)HeLacellswereinfectedwithlentiviralvectorsencodingashRNAtargetingMerlinoracontrolshRNAandsubjectedtoimmunoblotting(left)orstainingwithafﬁnity-puriﬁedantibodiestotheN-terminalsegmentofMerlinfollowedbyDAPI(right).(G)Theindicatedcellswerestainedasin(F).478Cell140,477–490,February19,2010ª2010ElsevierInc.thatMerlinintegratesantitheticsignalsfromcadherinsandintegrinstoregulatecell-cycleprogression.Merlinexertsinhibitoryeffectsonmultiplemitogenicsignalingpathways.TheclosedformofMerlinsuppressestherecruitmentofRactotheplasmamembraneandtheactivationofPAK(Kaempchenetal.,2003;Kissiletal.,2003;Okadaetal.,2005)andinhibitstheactivationofmTORC1independentlyofAkt(Jamesetal.,2009;Lo´pez-Lagoetal.,2009).Furthermore,MerlininhibitstheRas-ERKandPI-3K-Aktpathwaysandfocaladhesionkinase(FAK)-Srcsignaling(Ammounetal.,2008;Jinetal.,2006a;Poulikakosetal.,2006;Rongetal.,2004).Finally,MerlincooperateswiththerelatedERMproteinExpandedtoactivatetheHippotumor-suppressorpathwayinDrosophila(Choetal.,2006;Hamaratogluetal.,2006).However,thecontri-butionofeachoftheidentiﬁedpathwaystoNF2-dependenttumorigenesishasnotbeendeﬁned.Althoughyeasttwo-hybridscreensandotherapproacheshaveledtotheidentiﬁcationofseveralMerlin-bindingproteins,thebiochemicalfunctionofMerlinand,hence,themechanismthroughwhichitsuppressestumorigenesishaveremainedelusive.ThisstudyshowsthattheclosedformofMerlinentersthenucleus,bindstotheE3ubiquitinligaseCRL4DCAF1,andinhibitsitsactivity.Geneticevidenceindicatesthatthisinhibitoryinteractionisessentialfortumorsuppression.RESULTSTheClosedFormofMerlinBindstoDCAF1,theSubstrateReceptoroftheE3UbiquitinLigaseCRL4DCAF1Tandemafﬁnitypuriﬁcation(TAP)revealedthatMerlin,taggedateitheritsNoritsCterminus,associateswithproteinsdisplay-inganapparentmolecularweightof169kDand127kD(Figure1A).Thetwoproteinswererecoveredinsimilaramounts,eachatanapparentratioof1:5toMerlin.Importantly,thetumor-derivedmutantL64P,whichlackstumor-suppressoractivity(Gutmannetal.,2001),didnotassociatewiththeseproteins(Figure1A).MALDI-reTOF-MSfollowedbypeptidemassﬁngerprintingandmassspectrometricsequencingunequivocallyidentiﬁedthe127kDproteinasDDB1(DNADamage-Bindingprotein1)andthe169kDproteinasDCAF1(DDB1-andCul4-AssociatedFactor1)(Figure1A).NanoLC-MS/MSindicatedthatwild-typeMerlin,butnotMerlin-L64P,interactsalsowithCul4B,albeitatalowerapparentstoichiom-etry(TableS1availableonline).PriorstudieshaveestablishedthatDDB1functionsasaSKP1-likeadaptortorecruitWD40domain-containingsubstraterecep-tors,suchasDDB2,CSA(theCockaynesyndromeproteinA),andDet1-COP1totheE3ligaseCul4-Roc1(LeeandZhou,2007,andreferencestherein;O’ConnellandHarper,2007,andreferencestherein).DCAF1,whichwasoriginallyidentiﬁedasthecellularreceptorfortheHIVproteinVpranddesignatedVprBP,isoneofseveraladditionalWD40domainsubstratereceptorsabletocombinewithDDB1tomediateassemblyofdistinctCul4(CRL4)ligases(LeeandZhou,2007).Inagreementwiththemassspectrometricanalysis,immunoblottingindicatedthatFH-MerlincombineswithDCAF1,DDB1,andCul4,butnotDYRK2orEDD(Figure1B),componentsofthealternativeEDD-DYRK2-DDB1-VprBPE3ligasecomplex(MaddikaandChen,2009).TheseobservationsindicatethatMerlininteractsselectivelywiththeE3ligaseCRL4DCAF1.SinceMerlinformedastoichiometriccomplexwithDCAF1butnotDDB1uponcotransfectioninCos7cells(FigureS1A),wehypothesizedthatMerlinbindsdirectlytoDCAF1butindirectlytoDDB1.Totestthishypothesis,weexaminedtheabilityofGST-fusionproteinscomprisingeithertheFERMorthehelicalandC-terminaldomainofMerlintobindtoinvitrotranslatedDCAF1orDDB1.AsshowninFigureS1B,theFERMdomainofMerlinbounddirectlytoDCAF1butnotDDB1,whereasthehelicalandC-terminalsegmentsdidnot(FigureS1B).Thus,Merlinbindsdirectly,throughitsFERMdomain,toDCAF1.ToexaminewhethertheconformationaltransitionbetweentheopenandtheclosedformregulatesMerlin’sbindingtoCRL4DCAF1,wetestedthebehavioroftwowell-characterizedphosphorylationmutants.Merlin-S518A,whichcannotbephos-phorylatedatS518andisstabilizedintheclosedconformation,associatedefﬁcientlywithDCAF1andDDB1intransfected293Tcells.Incontrast,thephosphorylationsitemimeticmutantMerlin-S518D,whichisthoughttomaintainanopenconforma-tion,displayeddramaticallydiminishedbindingtoDCAF1andDDB1(Figure1C).Asanticipated,EzrinandMerlin-L64Pex-hibitedessentiallynobindinginthisassay.InagreementwiththemodelthattheclosedformofMerlinselectivelyinteractswithCRL4DCAF1,immunoblottingwithanti-P-MerlinantibodiesindicatedthatthefractionofrecombinantMerlinboundtoFH-DCAF1isnotdetectablyphosphorylatedatS518(Figure1D).Thus,theunphosphorylated,closedformofMerlininteractsspeciﬁcallywithCRL4DCAF1,whereastheopenformandawell-characterizedtumor-derivedmutantdonot,raisingthepossibilitythatMerlinsuppressescellproliferationandtumori-genesisbybindingtoCRL4DCAF1.MerlinAssociateswithCRL4DCAF1intheNucleusToidentifythecellularcompartmentwhereMerlininteractswithCRL4DCAF1,wecotransfectedMyc-taggedDCAF1andHA-taggedMerlinintoMerlin-deﬁcientMeso-33mesotheliomacells.Thesecellsundergogrowtharrestfollowingre-expressionofMerlinandthereforerepresentanexcellentmodeltostudythetumor-suppressorfunctionofMerlin(seebelow).Immunoﬂuo-rescentstainingindicatedthatMyc-DCAF1localizesinthenucleusinMeso-33cells(Figure1E),suggestingthatCRL4DCAF1functionsinthiscompartmentlikeotherCRL4ligases(Leeand(H)MCF-10Acellsweresubjectedtosubcellularfractionation.Equalamountsofproteinsfromthenuclear(NF)andnonnuclear(CM;cytosol+crudemembranes)fractionweresubjectedtoimmunoblottingwithantibodiestotheindicatedproteins.(I)Equalamountsofproteinsfromthenonnuclear(CM)andnuclear-soluble(NS)fractionofHeLacellsandMerlinimmunoprecipitateswereimmunoblottedasindicated.Anti-Cul4recognizesCul4-Aaswellasahighermolecularweightband,possiblycorrespondingtoneddylatedCul4-AorCul4-B(asterisk).SeealsoFigureS1.Cell140,477–490,February19,2010ª2010ElsevierInc.479Zhou,2007;O’ConnellandHarper,2007).Interestingly,inaddi-tiontolocalizingunderneaththeplasmamembrane,HA-Merlinalsoaccumulatedinthenucleus(Figure1E).Subcellularfraction-ationconﬁrmedtheseresults(FigureS1C).WereasonedthatpoorpermeabilizationofthenuclearmembraneorepitopemaskingmayhavehampereddetectionofMerlininthenucleusinpreviousimmunoﬂuorescencestudies(withtheexceptionofMuranenetal.,2005).Tostudythelocaliza-tionofendogenousMerlin,wedesignedaﬁxationandpermeabi-lizationprotocolabletocircumventthesepotentialproblems(seetheExperimentalProcedures).Usingthisprotocol,wefoundthatamonospeciﬁcantibodytotheN-terminalsegmentofMerlingeneratesprominentnuclearstaininginmultiplecelltypes,includingHeLasquamouscarcinomacellsandnonneoplasticHEI286Schwanncells,LP9mesothelialcells,andMCF-10Amammaryepithelialcells(Figures1Fand1G).ThispatternofstainingwasspeciﬁcbecauseitwassuppressedbysilencingofMerlin(Figure1F)andcouldbereproducedbyusinganantibodytoaC-terminalepitope(FiguresS1DandS1E).Finally,biochem-icalfractionationconﬁrmedthatMerlinandDCAF1accumulateinthenucleusinmultiplecelltypes(Figure1HandFigureS1F).Thus,MerlincanenterthenucleusandbindtoDCAF1.ManyCRL4ligasesassociatewithDNAorchromatinduringthecellcycleorinresponsetoDNAdamage(O’ConnellandHarper,2007).However,subnuclearfractionationindicatedthatbothDCAF1andMerlinaccumulateinthesolublenuclearfractionanddonotmoveintothechromatinfractionduringcell-cycleprogressionorinresponsetoUV-inducedDNAdamage(W.L.andF.G.G.,unpublisheddata),consistentwiththehypothesisthatCRL4DCAF1performsafunctiondistinctfromthatofotherknownCRL4ligases.Interestingly,coimmuno-precipitationanalysisshowedthatMerlincombineswithDCAF1,DDB1,andCul4inthesolublenuclearfraction,butnotinthenonnuclearfraction,despitethepresenceofabundantamountsofthesecomponents(Figure1I).Thissuggeststhatassociationwithacofactor,dissociationofaninhibitor,oraposttranslationalmodiﬁcationoccurringinthenucleuspromotetheassociationofMerlinwithCRL4DCAF1.Takentogether,theseresultsindicatethattheclosed,growth-inhibitoryformofMerlinbindstoCRL4DCAF1inthenucleus.MerlinIsNotaSubstrateofCRL4DCAF1ConstitutivelyactivatedAktcanpromotephosphorylationandproteasome-mediateddegradationofMerlin(Tangetal.,2007),andoverexpressionstudieshavesuggestedthatCRL4DCAF1mediatesthisprocess(HuangandChen,2008).However,experimentswithCycloheximideindicatedthatMerlinexhibitsahalf-lifefarexceeding24hrinseveralcelltypes(Fig-ureS2A).Inaddition,treatmentwiththeproteasomeinhibitorMG132didnotstabilizerecombinantMerlininCos7cells,andMerlin-S518DandMerlin-L64P,whichdonotinteractwithCRL4DCAF1,didnotdisplayincreasedstabilityinthisassay(FigureS2B).Finally,knockdownofDCAF1didnotcauseincreasedaccumulationofMerlininmultiplecelltypesunderstandardcultureconditions,orinHeLacellsacutelyexposedtomitogens(FiguresS2CandS2D).Infact,depletionofDCAF1decreasedthelevelsofMerlin,especiallyshortlyaftermitogenicstimulation,suggestingthatbindingtoDCAF1stabilizesMerlin(FigureS2D).TheseresultsarguethatMerlinisnottargetedfordegradationbyCRL4DCAF1andsuggestthatMerlinfunctionsupstream,notdownstream,ofCRL4DCAF1.MerlinInhibitsCRL4DCAF1ToexaminetheeffectofMerlinontheubiquitylatingactivityofCRL4DCAF1,wesetupaninvivoubiquitylationassay.Cos7cellsweretransfectedwithFH-DCAF1andMyc-ubiquitin,treatedwithMG132tostabilizeubiquitylatedproducts,andimmunopre-cipitatedwithanti-FlagtoisolateCRL4DCAF1andassociatedubiquitylatedproducts.Immunoblottingwithanti-MycantibodyrevealedthatFH-DCAF1isolatedfromMG132-treatedcellsco-precipitateswithubiquitylatedspeciesofapparentmolecularweightrangingfrom55to300kD,suggestingthatCRL4DCAF1ubiquitylatesinvivooneormoresubstratesandthattheseremainassociatedwiththeenzymethroughoutimmunoprecipi-tation(Figure2A,left).Incontrast,FH-DCAF1isolatedfromuntreatedcellscontainedamodestamountofubiquitylatedspeciesofapparentmolecularweightrangingfrom180to250kD.CotransfectionofincreasingconcentrationsofHA-Merlincausedadose-dependentsuppressionoftheaccumulationofubiquitylatedproducts,suggestingthatMerlinsuppressestheubiquitylatingactivityofCRL4DCAF1(Figure2Aleft).Immunoblot-tingwithanti-HAantibodyindicatedthatMerlindoesnotbecomeubiquitylateduponassociationwithDCAF1,consistentwiththenotionthatMerlinisaregulatorandnotasubstrateoftheligase(Figure2Aright).ImmunoblottingoftotallysatesprovidedacontrolfortheexpressionlevelsofrecombinantproteinsandindicatedthattreatmentwithMG132partiallystabilizesDCAF1(FigureS2E).TheseobservationssuggestthatMerlinbindstoCRL4DCAF1andsuppressesitsabilitytomediateubiquitylationoftargetproteins.Toconﬁrmthishypothesis,weexaminedwhetheramutantformofDCAF1unabletobindtoMerlinmediatesenhancedCRL4DCAF1ligaseactivityincellsexpressingendogenousMerlin.DeletionmappingindicatedthattheGST-FERMdomainofMerlinbindsdirectlytoa90aaC-terminalsegmentofDCAF1invitro(FigureS2F).Immunoprecipitationexperimentscon-ﬁrmedthatDCAF1(1–1417)lackingthisC-terminalsegmentcombineswithendogenousDDB1butnotwithHA-MerlininCos7cells(Figure2B).Interestingly,thismutantretainedtheabilitytointeractwiththeHIVproteinVpr(Figure2B),suggestingthatitisnotgrosslymisfoldedandindicatingthatMerlinandVprbindtodistinctsitesonDCAF1.Inaddition,mutationofthedoubleDxRboxonthebottomsurfaceoftheWD40propellerfoldofDCAF1(R1247/1283A)disruptedtheassociationofDCAF1withDDB1,aspreviouslyreported(Jinetal.,2006b),butnotwithMerlin(FigureS2G),indicatingthatdistinctsegmentsofDCAF1mediateinteractionwithDDB1andwithMerlin.Notably,invivoubiquitylationassaysrevealedthatligasecomplexescontainingDCAF1(1–1417)exhibithigherapparentenzymaticactivitythanthosecontainingwild-typeDCAF1inCos7cells(Figure2C).PretreatmentwithMG132causedalargeincreaseintheactivityofCRL4containingwild-typeDCAF1buthadonlyasmalleffectonCRL4containingDCAF1(1–1417)(Fig-ure2CandFigureS2E),suggestingthatthelatterisamorepotentE3ligase.TheseresultssuggestthatdeletionoftheMerlinbindingsegmentofDCAF1leadstoconstitutiveactivationof480Cell140,477–490,February19,2010ª2010ElsevierInc.CRL4DCAF1,consistentwiththenotionthatMerlininhibitstheE3ligaseactivity.Finally,wetestedtheeffectofdepletionofMerlinonCRL4DCAF1activity.Cos7cellswereinfectedwithlentivirusesen-codingacontrolshorthairpinRNA(shRNA)orashRNAtargetingMerlinandthensubjectedtoinvivoubiquitylationassay.TheresultsindicatedthatdepletionofMerlincausesasigniﬁcantincreaseinCRL4DCAF1ligaseactivity(Figure2D).TheeffectoftheshRNAtargetingMerlinwasspeciﬁc,becauseitwassup-pressedbyoverexpressionofHA-MerlinbutnotofHA-Ezrin,whichdoesnotassociatewithFH-DCAF1(FiguresS2HandS2I).Together,theresultsofpositiveexpression,mutationalactivation,anddepletionprovidecompellingevidencethatMerlinfunctionsasanegativeregulatorofCRL4DCAF1(seeFigure2Eforahypotheticalmodel).CRL4DCAF1MediatestheHyperproliferationCausedbyInactivationofMerlinRecentstudieshaveimplicatedCRL4DCAF1inDNAreplicationandprogressionthroughtheG2phaseofthecellcycle(Hreckaetal.,2007;McCalletal.,2008).ToexaminewhetherMerlinsuppressescellproliferationbyinhibitingCRL4DCAF1,wesilencedDCAF1inNF2mutantMeso-33mesotheliomacellsusingasmartpoolofsmallinterferingRNAs(siRNAs)(Fig-ureS3A).SincelossofMerlinpromotesprogressionthroughG1(Lo´pez-Lagoetal.,2009),weexaminedwhetherlossofDCAF1affectsthisspeciﬁcphaseofthecellcycle.BrdUincor-porationexperimentsrevealedthatdepletionofDCAF1inhibitstheabilityofG0synchronizedMeso-33cellstoprogressthroughG1andenterSphaseinresponsetomitogens(Figure3A).DeconstructionofthesmartpoolindicatedthateachindividualsiRNAinthepoolwasabletoinhibitexpressionofDCAF1andcellproliferation,asexpectedfromspeciﬁcinhibition(FiguresS3BandS3C).Incontrast,silencingofDCAF1exertedamoderategrowthinhibitoryeffectinnormalmesothelialMet-5Acells(Figure3BandFigureS3D),suggestingthatMerlin-deﬁ-cientcellsaremoresensitivetoinactivationofDCAF1thantheirnormalcounterpart.TofurtherexploretheroleofCRL4DCAF1intheproliferationofMerlin-deﬁcienttumorcells,wedesignedashRNAabletotargetFigure2.MerlinInhibitsCRL4DCAF1-Depen-dentUbiquitylation(A)Cos7cellsweretransfectedwith3mgFH-DCAF1and2mgMyc-UbiquitinincombinationwiththeindicatedamountsofHA-MerlinandtreatedwithMG132orleftuntreated.Flagorcontrolimmunoprecipitates(M2andC,respec-tively)weresubjectedtoimmunoblottingwithanti-Myctovisualizeubiquitylatedproteins(left)oranti-HAtovisualizeDCAF1andMerlin(right).UpperarrowpointstoDCAF1andlowerarrowtoMerlin.(B)Cos7cellsweretransfectedwithFH-DCAF1orFH-DCAF1(1–1417)incombinationwithHA-Merlin(toppanel)orHA-Vpr(bottompanel).Flagorcontrolimmunoprecipitatesweresub-jectedtoimmunoblotting.LevelsofexpressionofDCAF1,DDB1,andMerlinorVprwereveriﬁedbyimmunoblottingaliquotsoftotallysates.(C)Asin(B),withcotransfectionofMyc-UbiquitinandtreatmentornotwithMG132.Flagorcontrolimmunoprecipitateswereimmunoblottedwithanti-Myc(left)oranti-HA(right).(D)Cos7cellsstablyinfectedwithlentiviralvectorsencodingacontrolshRNAorashRNAtargetingMerlinweresubjectedtoimmunoblotting(left)ortransfectedwithFH-DCAF1andMyc-UbiquitinfollowedbyimmunoblottingofFlagorcontrolimmunoprecipitateswithanti-Myc(middle)oranti-HA(right).(E)HypotheticalmodelofMerlin-mediatedinhibi-tionofCRL4DCAF1.MerlinisproposedtofunctionasacompetitiveinhibitorofCRL4DCAF1.Bluehexagons,threebpropellerfoldsofDDB1,whichcontactCul4(B)andDCAF1(AandC);yellowhexagon,WD40domainofDCAF1;yellowsticks,doubleDxRboximplicatedinbindingtoDDB1;S,substrate;Ub,ubiquitin;Mer,closedMerlin.SeealsoFigureS2.Cell140,477–490,February19,2010ª2010ElsevierInc.481bothhumanandmouseDCAF1.SilencingofDCAF1withthisshRNAinhibitedphosphorylationofRbandentryintotheSphaseinMeso-33cells(FigureS3E).FACSanalysisofunsyn-chronizedMeso-33cellsconﬁrmedthatdepletionofDCAF1predominantlyinhibitsprogressionthroughG1(controlMeso-33:23%G1,68%S,9%G2/M;DCAF1-depletedMeso-33:59%G1,35%S,6%G2/M).Re-expressionofDCAF1fromeitheramoderateorastrongpromoterrescuedphosphorylationofRbandcell-cycleprogression,conﬁrmingthespeciﬁcityoftheshRNAtargetingDCAF1(FigureS3E).WethereforeusedthisshRNAtosilenceDCAF1inFC-1801Schwannomacells,whichwerederivedfromNF2conditionalknockoutmice,andtheirnormalcounterpart,theFH-912cells.Notably,inactivationofDCAF1causedamoreprofoundgrowthinhibitioninMerlinnullFC-1801cellsascomparedtoMerlin-positiveFH-912cells(FigureS3F),conﬁrmingthatCRL4DCAF1isrequiredfortheprolif-erationofMerlin-deﬁcienttumorcellsbuttoalesserdegreeforthatofnormalcells.TheseobservationssuggestthatCRL4DCAF1isakeycomponentoftheoncogenicsignalingpathwayacti-vatedbylossofMerlin.ToexaminewhetherCRL4DCAF1isrequiredforexitfromcontactinhibitionafterinactivationofMerlin,wesilencedMerlininconﬂuenthumanumbilicalveinendothelialcells(HUVECs).Asanticipated,thismanipulationinducedasigniﬁcantfractionofconﬂuentHUVECstoenterintoSphase(Figure3C).Notably,depletionofDCAF1witheachoftwodistinctsiRNAssuppressedthisunscheduledevent(Figure3C),suggestingthatMerlininducescontactinhibitionthroughinhibitionofCRL4DCAF1.ToconﬁrmthatCRL4DCAF1functionsdownstreamofMerlin,weconductedanadditionalgeneticepistasisexperimentinHEI-286Schwanncells,whichareimmortalizedbutnotneoplastic.SilencingofMerlincausedthesecellstoundergoacceleratedprogressionthroughG1andentryintoSphaseinresponsetogrowthfactors(Figure3D),inagreementwiththeobservationthatMerlincontributestorestrainingG1progression(Lo´pez-Lagoetal.,2009).InactivationofDCAF1revertedthehyperproliferationcausedbydepletionofMerlinbutdidnotaffecttherateofgrowthofcontrolcellsexpressingMerlin(Figure3D),providingadditionalevidencethatCRL4DCAF1medi-atesthegrowthinhibitoryeffectofMerlin.IfMerlinsuppressescellproliferationbyinhibitingCRL4DCAF1,expressionofamutantformofDCAF1unabletointeractwithMerlinshouldcounteracttheantimitogeniceffectofMerlin.Totestthisprediction,wetransfectedMeso-33cellswithFH-Merlin,aloneorincombinationwithwild-typeDCAF1orDCAF1(1–1417),andsubjectedthemtoBrdUincorporationassay.Interestingly,expressionofDCAF1(1–1417)fullyrescuedMeso-33cellsfromundergoinggrowtharrestuponintroductionofMerlin,whereaswild-typeDCAF1hadonlyamoderateeffect(Figure3E).Wenotethat,inspiteofitshigherlevelofexpression,Figure3.DCAF1MediatesHyperproliferationandLossofContactInhibitioninMerlin-DeﬁcientCells(AandB)Meso-33cells(A)andMet-5acells(B)weretransfectedwithaSMARTpoolofsiRNAstargetingtheadaptorproteinAP3b,DCAF1,oracontrolnontargetingpool,deprivedofgrowthfactorsfor24hr,incubatedwithBrdUinthepresenceofmitogensfor24hr,andsub-jectedtoanti-BrdUstainingfollowedbycounterstainingwithDAPI.Thegraphshowsthepercentage(±standarderrorofthemean[SEM])ofBrdU+cellsandthepicturesshowrepresentativeﬁelds.(CandD)HUVECs(C)andHEI286humanSchwanncells(D)weretransfectedwithacontrolsi-RNAortwodistinctsi-RNAstargetingDCAF1,aloneorincombinationwithapreviouslyvalidatedsi-RNAtargetingMerlin(Okadaetal.,2005).Cellsweredeprivedofgrowthfactorsfor24hr,platedunderconﬂuent(C)orsparse(D)conditionsonﬁbronectin,andsubjectedtoBrdUincorporationinthepresenceofmitogensfor24hrfollowedbyanti-BrdUstaining.Thegraphsshowthepercentage(±SEM)ofBrdU+cells.Immunoblottingwasusedtoverifytheefﬁciencyofknockdown.(E)Meso-33cellsweretransientlytransfectedwiththeindicatedmgofvectorsencodingHA-Merlin,aloneorincombinationwithFH-DCAF1orFH-DCAF1(1–1417),andsubjectedtoimmunoblotting(left)andBrdUincorporationassay(right).Theanti-HAblotsincludingFH-DCAF1andHA-Merlinwereexposedforthesametime.Thegraphshowsthepercentage(±SEM)ofBrdU+cells.SeealsoFigureS3.482Cell140,477–490,February19,2010ª2010ElsevierInc.Merlindidnotbindstoichiometricallytowild-typeDCAF1undertheseexperimentalconditions(FigureS3G).Presumably,tran-sienttransfectionsaturatesthecellularmachinerythatmodiﬁesMerlintoenableittobindtoCRL4DCAF1inMeso-33cells.Takentogether,theseresultsprovidestrongevidencethatMerlinsuppressescellproliferationbyinhibitingCRL4DCAF1.Merlin-MediatedInhibitionofCRL4DCAF1ActivatesaGrowth-InhibitoryGeneExpressionProgramCRL4ligasescanregulategeneexpressionbypromotingubiq-uitylationofhistonesandrecruitmentofenzymesinvolvedinchromatinremodelingorhistonemethylationorbyinducingproteasome-mediateddegradationoftranscriptionfactors(O’ConnellandHarper,2007).ToexaminewhetherMerlincontrolsgeneexpressionthroughinhibitionofCRL4DCAF1,wecomparedthegeneexpressionprogramactivatedbyexpressionofMerlinordepletionofDCAF1inNf2 / FC-1801mouseSchwannomacells.Unsupervisedclusteringof1566probesetsdifferentiallyexpresseduponexpressionofwild-typebutnotL64PmutantMerlinoruponspeciﬁcdepletionofDCAF1re-vealedlargelyoverlappingchangesingeneexpression(Figure4A).Infact,expressionofMerlinanddepletionofDCAF1inducedaconcordantupregulationordownregulationof855probesets(54%)(Figure4BandFigureS4A).Inspiteofthisconsiderablefunctionaloverlap,expressionofMerlinandknockdownofDCAF1alsoinducedspeciﬁceffectsongeneexpression(Figure4B).TheseresultsindicatethatMerlinregu-latesgeneexpressionlargelythroughinhibitionofCRL4DCAF1butalsosuggestthatMerlinhasCRL4DCAF1-independentfunctions.IngenuitypathwayanalysisrevealedthatexpressionofMerlinandinactivationofCRL4DCAF1causeaconcordantdownregula-tionofgenespromotingcell-cycleprogressionandupregulationofgenesinvolvedingrowtharrestandapoptosis(Figure4C).Inaddition,thesetwomanipulationsdownregulatedseveralcelladhesiongenes,suchastheintegrinasubunitsItga6andItga7,theintegrincounter-receptorVcam1,andtheintegrin-linkedkinaseIlk,andupregulatedtheRhoeffectorsRock1andFigure4.ExpressionofMerlinandDepletionofDCAF1InduceaLargelyOverlappingGeneExpressionProgram(A)FC-1801cellswereinfectedwithlentiviralvectorsencodingashRNAtargetingDCAF1(sh-DCAF1),acontrolshRNA(sh-Control),wild-typeMerlin,Merlin-L64P,orsh-DCAF1incombinationwithwild-typeMerlinandsubjectedtoDNAmicroarrayanalysis.Unsupervisedclusteringof1566probesetsdifferentiallyexpressedR2foldinatleastoneofthetwomajorcomparisons(sh-DCAF1versussh-ControlandMerlin-WTversusMerlin-L64P).Valueswerenormalizedtoparentaluninfectedcells.(B)VenndiagramshowstheoverlapbetweenthelistofgenesdifferentiallyexpresseduponexpressionofMerlin-WTorsilencingofDCAF1(R2-foldchange).Coregulatedgenes(885)areidentiﬁedasdifferentiallyexpressedR2-foldinoneofthetwocomparisonsanddisplayingaconsensualsigniﬁcantchangeintheothercomparison(p%0.01bytheANOVAtest).(C)Sixhundredandsixty-sevengenescoregulateduponexpressionofMerlin-WTorsilencingofDCAF1(R2-foldchangeinbothcomparisons)weresubjectedtoingenuitypathwayanalysis.Bothdownregulated(353)andupregulated(314)genesareincludedinthecategoryofbiologicalfunctions.Representativedown-regulatedgenesareshowninblue,andrepresentativeupregulatedgenesinredinorderofdecreasingaveragefoldchange.SeealsoFigureS4.Cell140,477–490,February19,2010ª2010ElsevierInc.483Limk1.IngenuityanalysisofcanonicalpathwaysindicatedthatexpressionofMerlinandlossofDCAF1inhibitintegrinandPDGFsignalingaswellasthesignalingpathwaysjointlyregu-latedbyintegrinsandreceptortyrosinekinases(FigureS4B).Interestingly,thesetwomanipulationsalsoledtodownregula-tionoftheintegrinsignalingcomponentBcar3,whichhasbeenimplicatedinrecruitmentofp130CAStolamellipodiaandinacti-vationofRac(Schrecengostetal.,2007).AsurveyofthegenescoordinatelyregulatedbyexpressionofMerlinorlossofDCAF1revealedadditionalfeaturesofthegeneexpressionprogramactivatedbyMerlinthroughinhibitionofCRL4DCAF1.Inadditiontoexpandingthecategoryofgenesinvolvedincelladhesionandreceptortyrosinekinasesignaling,thisanalysisrevealedthatMerlinregulates,throughCRL4DCAF1,severalgenesinvolvedinintracellulartrafﬁckingandafractionoftheknownHippopathwaytargetgenes(FigureS4C).TheseobservationssuggestthatMerlin’sinhibitionofCRL4DCAF1activatesabroadtumor-suppressivegeneexpressionprogram.IntramolecularAssociationoftheFERMDomainwiththeC-TerminalTailPromotesNuclearAccumulationofMerlinInordertoobtaininsightintotheregulationoftheassociationofMerlinwithCRL4DCAF1,westudiedthemechanismthatenablesMerlintoaccumulateinthenucleus.PreliminaryexperimentsindicatedthatMerlin’stranslocationinthenucleusdoesnotrequireDCAF1(W.L.andF.G.G.,unpublisheddata).SinceMerlindoesnotcontainacanonicalnuclearimportsequence,weexaminedtheabilityoftheFERMdomainandofthea-helicalandC-terminaldomainoftheproteintolocalizetothenucleus.TheFERMdomainofMerlin(1–341)accumulatedinthenucleusofMeso-33cellstoasigniﬁcantlylargerdegreeascomparedtowild-typeMerlin.Incontrast,thea-helicalandC-terminaldomainoftheprotein(341–595)failedtolocalizetothenucleusunderthesameconditions(FiguresS5AandS5B).TheseresultsindicatethattheFERMdomainofMerlinissufﬁcientfornucleartranslocationandsuggestthattheC-terminalportionoftheproteinmayexertaninhibitoryrole.SincethisportionofMerlincontainsanuclearexportsignal(KresselandSchmucker,2002),itispossiblethatthissignalismaskedintheclosedconformer.Toexaminewhetherantimitogenicsignals,suchascell-to-celladhesionandgrowthfactordeprivation,regulatetheaccumula-tionofMerlininthenucleus,wemonitoredthesubcellularlocal-izationoftheunphosphorylatedandphosphorylatedformofMerlinundervariousgrowthconditions.Mobilityshiftassayandimmunoblottingwithanti-P-Merlin(S518)indicatedthatthedephosphorylatedformofMerlin,whichwasprevalentinconﬂuentcellsespeciallyiftheywerenotexposedtomitogens,accumulatedpredominantlyinthenucleus,whereasMerlinphosphorylatedatS518remainedlargelyconﬁnedtothenon-nuclearfractionunderallconditions(FiguresS5CandS5D).Toconﬁrmthattheclosed,growth-inhibitoryformofMerlinaccumulatespreferentiallyinthenucleus,weexaminedthesubcellulardistributionofMerlin-S518A,whichcannotbephosphorylatedbyPAK,andMerlin-S518D,whichmimicsthephosphorylatedformoftheprotein.Notably,Merlin-S518Aaccumulatedinthenucleustoasigniﬁcantlyhigherextentthandidwild-typeMerlin(FigureS5E).Incontrast,Merlin-S518Ddisplayeddefectivenuclearaccumulation,suggestingthatPAK-mediatedphosphorylationinhibitsnuclearlocalizationofMerlin.Inagreementwiththishypothesis,adominantnegativeformofPAKenhancednuclearaccumulationofMerlin(W.L.andF.G.G.,unpublisheddata).Thus,intramolecularassociationoftheFERMdomainwiththeC-terminaltailpromotesnuclearaccumulationofMerlin,whereasphosphorylationofS518inhibitsthisprocess.Tumor-DerivedMutationsPreventMerlin’sAbilitytoInteractwithortoInhibitCRL4DCAF1MostNF2missensemutationsmaptotheFERMdomain(Ahro-nowitzetal.,2007).TofurtherstudytherelevanceofMerlin’sinteractionwithCRL4DCAF1fortumorsuppression,weexaminedseveralofthesemutations.L46R,F62S,L64P,L141P,A211D,andE270GhavebeenfoundintwoormoreunrelatedNF2patientsorareknowntotrackwithdiseaseinindividualfamiliesandarethereforebonaﬁdepathogenicmutations.Incontrast,G197C,whichwasidentiﬁedinasinglepatientaffectedbymildbilateralSchwannoma,mayrepresentapolymorphismorapassengermutation(Ahronowitzetal.,2007).StructuralconsiderationssuggestthatL46R,F62S,L64P,L141P,andA211DdisruptthehydrophobiccoreofsubdomainAorB,whereasE270Gsimplyremovesasurfacechargefromsubdo-mainC(Figures5A–5C).Incontrast,G197Ccanbeaccommo-datedbyaslightadjustmentofthesurfaceloopinwhichitresides,withoutoverteffectsontheoverallstructureofsubdo-mainB,anddoesnotintroduceordeleteacharge(Figure5C).Toevaluatetheirgrowth-suppressivefunction,weintroducedMerlinandmutantsthereofintoMeso-33cells.Asanticipated,wild-typeMerlinandMerlin-S518AsuppressedprogressionthroughG1andentryinSphaseinthesecells,whereasMerlin-S518Dinhibitedproliferationtoamuchsmallerdegree(Figure5D).Notably,allthebonaﬁdepathogenicmutantswerefoundtobedevoidofgrowthinhibitoryactivityinMeso-33cells.Incontrast,MerlinG197Csuppressedproliferationaseffectivelyaswild-typeMerlin,suggestingthatthisisnotapathogenicmutation(Figure5D).Toexaminetheabilityoftumor-derivedmutantsofMerlintointeractwithCRL4DCAF1incells,wesub-jectedCos7cellsexpressingFH-Merlinandmutantsthereoftocoimmunoprecipitation.Remarkably,allthebonaﬁdetumor-derivedmutantformsofMerlindidnotinteractwithCRL4DCAF1invivo,whereasthecontrolmutantG197Cassociatedwiththeligaseasefﬁcientlyaswild-typeMerlinunderthesamecondi-tions(Figure5E,seeFigure1CforL64P),providingevidencethatMerlinneedstocombinewithCRL4DCAF1tosuppresstumorigenesis.ToobtaininsightintothemechanismthroughwhicheachofthesepathogenicmissensemutationsimpairsassociationofMerlinwithCRL4DCAF1invivo,weﬁrstassessedtheireffectonnuclearaccumulationoftheprotein.Biochemicalfraction-ationindicatedthatL46R,L64P,L141P,andA211Daccumu-lateinthenucleustoamuchsmallerdegreethanwild-typeMerlinorG197C(Figures6Aand6B).Defectivenucleartrans-locationanddecreasedlevelofexpression,presumablyarisingfromdeﬁcientproteinstability,contributedtovaryingdegreestoinhibitaccumulationofeachofthesemutantsintothe484Cell140,477–490,February19,2010ª2010ElsevierInc.nucleus.Atthetwooppositeendsofthespectrum,L46RandL141didnotaccumulateinthenucleusinspiteofnearwild-typelevelsofexpression,suggestingthatthesetwomutationsaffectpredominantlynucleartranslocation,whereasA211Dnuclearlevelswerelowlargelyasaconsequenceofreducedexpression(Figures6Aand6B).Incontrast,F62SandE270translocatedintothenucleusasefﬁcientlyaswild-typeMerlin,althoughtheamountsofthelatterinthenucleusappearedtobereduced.Theseresultssuggestthatdefectivestabilityandnucleartranslocationcontributetoimpairtheinteractionofcertaintumor-derivedmutantformsofMerlinwithCRL4DCAF1.Toexaminetheabilityoftumor-derivedmissensemutantstointeractwithCRL4DCAF1invitro,weengineeredeachmutationintoafusionproteincomprisingtheisolatedFERMdomainofFigure5.SeveralPathogenicMissenseMutationsDisruptBindingofMerlintoCRL4DCAF1InVivo(A)Tumor-derivedmutants(redsticks)areshowninthecontextoftheoverallstructureoftheFERMdomainofhumanMerlin(coloredribbons;PDB1ISN).Thea-helicalcoiled-coildomainfromthecrystalstructureoftheclosedformofSpodopterafrugiperdaMoesin(thingraya-carbontrace;PDB2I1K),whichishighlyhomologoustohumanMerlin,isshownforreference.Thecoiled-coildomainwaspositionedbysuperimposingtheFERMdomainsfromthestructuresofMerlinandMoesin,whichhavearootmeansquaredeviationfora-carbonatomsof1.3A˚andshare62%sequenceidentity.(B)Close-upviewoftumor-derivedmutations(redsticks)locatedinsubdomainA(greenribbon)inthecrystalstructureofhumanMerlin.Residuesincontactwithmutatedresiduesaredrawnassticksandcoloredaccordingtoatomtype(carbon,yellow;sulfur,green).(C)SubdomainBrepresentedasin(B),withoxygenasmagentasticks.Redsphere,G197.(D)Meso-33cellsweretransientlytransfectedwithemptyvectororvectorsencodingwild-typeMerlinorindicatedmutants.Asynchron-izedcellsgrowingin10%fetalcalfserumweresubjectedtoBrdUincorporationassay.Thegraphindicatesthepercentage(±SEM)ofBrdU-positivecells.Picturesshowrepresentativeﬁeldsofcellstrans-fectedwithindicatedvectorsandstainedwithanti-BrdU(red)andDAPI(blue).(E)Cos7cellsweretransfectedwithFH-taggedversionsofwild-typeMerlinorindicatedmutants.Flagorcontrolimmunoprecipitates(M2andC,respectively)andtotallysateswereimmunoblottedasindicated.SeealsoFigureS5.Merlin,whichwehadshownbindsefﬁcientlytoinvitrotranslatedDCAF1.AsshowninFigures6Cand6D,GST-FERM-A211DboundtoDCAF1invitroalmostasefﬁcientlyaswild-typeGST-FERMorGST-FERM-G197C,suggestingthattheA211DmutantdoesnotinteractinvivowithCRL4DCAF1becauseitdoesnotaccumulateinthenucleustosufﬁcientlevels(Figures6Aand6B).AlltheothermutantFERMdomainsdis-playeddecreasedabilitytobindtorecombinantDCAF1:L46R,L64P,andE270Gdidnotbindatallunderourexperimentalconditions,whereasF62SandL141Pdisplayeddefectivebinding(Figures6Cand6D).SinceF62SandE270Gwereabletoaccumulateinthenucleustonormalornear-normallevels(Figures6Aand6B),weinferthattheydonotcombineinvivowithCRL4DCAF1becausetheyareunabletointeractdirectlywithDCAF1withsufﬁcientafﬁnity.Notably,theE270Gmutationsimplyremovesachargefromasurfaceexposedlooponsub-domainC(Figure5A),implicatingthisloopininteractionwithDCAF1andconﬁrmingthehighspeciﬁcityoftheinteractionofMerlinwithDCAF1.Incontrast,bothdefectivenuclearaccumu-lationanddeﬁcientbindingtoDCAF1contributetotheinabilityofL46R,L64P,andL141PtointeractwithCRL4DCAF1invivo.Together,theseexperimentsindicatethatthesixtumor-derivedmissensemutantsthatwehavetesteddonotcombinewithCRL4DCAF1invivo,owingtodefectiveaccumulationinthenucleus,deﬁcientbindingtoDCAF1,oracombinationofthetwomechanisms.WhilemutationsthatintroducestopcodonswithintheFERMdomainarelikelytogiverisetomisfoldedandunstableproteinCell140,477–490,February19,2010ª2010ElsevierInc.485products,certainnonsensemutationsdeleteonlytheC-terminaldomain—astructuralperturbationthatmayaffecttheabilityofMerlintomaintainaclosedconformation.Toexaminewhethertumor-derivednonsensemutationsaffecttheabilityofMerlintointeractwithortosuppressCRL4DCAF1,weexaminedtwoFigure6.PathogenicMutationsDisrupttheAbilityofMerlintoAccumulateintheNucleus,toBindtoDCAF1,ortoInhibitCRL4DCAF1(A)Meso-33cellsweretransientlytransfectedwithFH-taggedversionsofwild-typeMerlinortheindicatedmutantsandsub-jectedtosubcellularfractionation.Equalamountsofproteinsfromthenonnuclear(CM)andnuclear(NF)fractionsweresub-jectedtoimmunoblotting.(B)TheamountofMerlinorindicatedmutantspresentinnuclearandnonnuclearfractionswasestimatedbydensitometryoftheblotin(A).Top:ratioofMerlinorindicatedmutantspresentinnuclearversusnonnuclearfractions.Bottom:amountofeachMerlinmutantpresentinthenucleusasapercentageoverthewild-typevalue.(C)Invitro-translatedandTNT-labeledDCAF1wasincubatedwith0.5,1,and2mgGSTfusionproteinscomprisingtheFERMdomainofwild-typeMerlinorindicatedmutants.GST-boundDCAF1wasdetectedbyblottingwithHRP-streptavidin.(D)Densitometricanalysisof(C).Thegraphshowsthebindingvaluesinarbitraryunits.(E)Cos7cellsweretransfectedwiththeindicatedFH-taggedformsofMerlinandsubjectedtoimmunoprecipitationwithcontrol(C)oranti-FlagMab(M2)followedbyimmunoblotting.(F)Cos7cellsweretransfectedwithFH-DCAF1andHA-UbiquitinincombinationwiththeindicatedMyc-taggedconstructsoremptyvectorandtreatedwithMG132.Flagorcontrolimmunopre-cipitateswereimmunoblottedwithanti-HA(left).Totallysateswereimmunoblottedwithanti-Myc(right).prevalenttruncationmutants:Merlin466X,whichlackstheC-terminalportionofthea-helicaldomainaswellastheC-terminaldomain,andMerlin341X,whichretainstheFERMdomainbutlacksboththea-helicalandtheC-terminaldomains(Ahronowitzetal.,2007).CoimmunoprecipitationindicatedthatthesetwoMerlinmutantsretaintheabilitytointeractwithCRL4DCAF1invivo(Figure6E).Infact,progressivedeletionfromtheCterminusresultedinincreased,asopposedtodecreased,bindingofMerlintotheligase.SincetheisolatedFERMdomainofMerlinaccumu-latesinthenucleustoalargerextentthanthewild-typeprotein,whereastheC-terminalportionofMerlinincludingthea-helicalandC-terminaldomainremainsinthecytoplasm(FigureS5B),itispossiblethatincreasednuclearaccumulationfacilitatestheinterac-tionoftumor-derivedtruncationsmutantswithCRL4DCAF1.Interestingly,inspiteofitsincreasedabilitytobindtoCRL4DCAF1invivo,theFERMdomainofMerlindidnotsuppressCRL4DCAF1ligaseactivityinvivoasefﬁcientlyaswild-typeMerlin(Figure6F),indicatingthatthea-helicalandC-terminaldomainscontributetoMerlin’sinhibitoryactivity.Theseresultssuggestthatthetumor-derivedtruncationmutantsofMerlinthatretaintheFERMdomainareabletointeractwithCRL4DCAF1butfailtosuppressitsactivity.Theobservationthatseveraldistincttumor-derivedmutationsimpairMerlin’sabilitytotranslocateintothenucleus,tobindtoDCAF1,ortoinhibitCRL4DCAF1activityprovidesstronggeneticevidencethatMerlinsuppressestumorigenesisbyinhibitingCRL4DCAF1.486Cell140,477–490,February19,2010ª2010ElsevierInc.InactivationofDCAF1SuppressestheTumorigenicPotentialofMesotheliomaandSchwannomaCellsTotestwhetherCRL4DCAF1isrequiredforNF2-dependenttumor-igenesis,wesilencedDCAF1inMeso-33andFC-1801cells(Figures7Aand7B).KnockdownofDCAF1inhibitedtheabilityofbothmesotheliomaandSchwannomacellstogrowinsoftagar(Figure7CandFigureS6A).Incontrast,depletionofDCAF1didnotaffecttheabilityofRas-V12orv-SrctransformedcellstoexpresselevatedlevelsofCyclinD1andp-Rbandtoprolif-erateunderadherentconditionsorinsoftagar(FiguresS6BandS6C),suggestingthatinactivationofCRL4DCAF1speciﬁcallyinhibitsthemalignantpropertiesofMerlin-deﬁcienttumorcells.Meso-33cellsaswellasotherMerlin-deﬁcientmesotheliomacelllinesdidnotgiverisetotumorsuponsubcutaneousorintra-pleuralinjectioninmice.Incontrast,theFC-1801cells,whichexpressrobustlevelsofDCAF1,gaverisetosizeabletumorsinlessthan4weeksuponsubcutaneousinjectioninnudemice(Figure7D).SilencingofDCAF1withtwodistinctshRNAsin-hibitedtumorgrowthinvivobyapproximately75%atday24.Thiseffectwashighlyspeciﬁc,asmoderateoverexpressionofashRNA-resistantformofDCAF1rescuedtheabilityofFC-1801cellsexpressingoneofthetwoshRNAstargetingDCAF1togiverisetosubcutaneoustumors(Figure7E).Infact,thetumorsgeneratedbythesecellsgrewatamuchfasterpaceascomparedtothosegeneratedbyparentalFC-1801cells(byapproximately2-fold,compareFigures7Dand7E,dataarefromthesameexperiment),suggestingthatelevatedlevelsofDCAF1canpromotetumorigenesis.ToexploretherelevanceofourﬁndingstothepathogenesisofNF2,weexaminedwhetherDCAF1affectstheabilityofprimaryhumanSchwannomacellsderivedfromNF2patientstoprolif-erateinvitro.SilencingofDCAF1suppressedtheabilityofthesecellstoprogressthroughG1andenterintoSphaseinresponsetomitogens.Incontrast,knockdownofDCAF1didnotsigniﬁ-cantlyaffecttheproliferationofcontrolhumanSchwanncells(Figure7F).Together,theseresultsindicatethatCRL4DCAF1isnecessaryforNF2-dependenthyperproliferation,anchorage-independentgrowth,andtumorigenesis.DISCUSSIONThemechanismbywhichMerlinsuppressestumorigenesishasremainedelusivesincethediscoveryoftheNF2gene.Thisstudyrevealsthattheclosed,growth-inhibitoryformofMerlintranslo-catestothenucleus,bindstotheE3ubiquitinligaseCRL4DCAF1,andsuppressesitsabilitytoubiquitylatetargetproteins.MultipleconverginglinesofevidenceindicatethatMerlin’sinhibitionofCRL4DCAF1activityisrequiredtoinducegrowtharrestandsuppresstumorigenesis.Notably,analysisofseveraltumor-derivedmutantsindicatesthatsomedisplayimpairednucleartranslocation,othersfailtointeractwithDCAF1,andstillothersbindtoDCAF1butdonotsuppressCRL4DCAF1E3ligaseactivity.Furthermore,silencingofDCAF1reversestheconsequencesofMerlininactivationinnormalcellsandsuppressestheabilityofMerlin-deﬁcienttumorcellstogrowinsoftagarandinnudemice.Theseﬁndingsindicatethatentryintothenucleusandinhi-bitionofCRL4DCAF1areintegralcomponentsofthemechanismbywhichMerlinsuppressestumorigenesis.ThemechanismsthroughwhichantimitogenicsignalsinduceMerlintoinhibitCRL4DCAF1arelikelytobecomplex.Ourresultssuggestthatthesesignalspromote,largelythroughinhibitionofPAK,accumulationoftheclosedformofMerlin,whichFigure7.SilencingofDCAF1SuppressestheTumorigenicPotentialofMerlin-DeﬁcientCells(A)Meso-33cellswereinfectedwithlentiviralvectorsencodingtwodistinctshRNAstargetingDCAF1(sh-1andsh-2)oracontrolshRNA(sh-Contr.)andsubjectedtoimmunoblotting.(B)FC-1801cellstreatedasin(A).Cellsinfectedwithsh-1werealsoinfectedwitharetroviralvectorencodingashRNA-resistantversionofDCAF1orwithemptyvector.Immunoblottingwasasindi-cated.(C)Meso-33cellsinfectedwiththeindicatedlenti-viralvectorsweresubjectedtosoftagarassay.Thegraphillustratesthetotalnumber(±SEM)ofcoloniespresentineachwellafter2weeksofculture.Representativeimagesareshown.(DandE)TwomillionFC-1801cellsinfectedwiththeindicatedlentiviralvectorswereinjectedsubcutaneouslyinnudemice.(D)showstheincreaseinvolume(±SEM)overtimeoftumorsgeneratedbycellsinfectedwithlentivirusesencodingacontrolshRNA(sh-Control)ortwodistinctshRNAstargetingDCAF1(sh-1andsh-2).(E)showstheincreaseinvolume(±SEM)overtimeoftumorsgeneratedbycellsinfectedwithsh-1andeitheraretroviralvectorencodingashRNA-resistantversionofDCAF1oremptyvector.Datawereobtainedfromthesameexperiment.Notethedifferentscaleoftheyaxesofthetwographs.(F)PrimarySchwanncellsfromtwonormalindividuals(NF2+/+)andSchwannomacellsfromtwoNF2patients(NF2 / )wereinfectedwithlentivirusesencodingashRNAtargetingDCAF1(sh-2)oracontrolshRNA(sh-Co.),deprivedofgrowthfactors,restimulatedwithmitogensinthepresenceofBrdU,andsubjectedtoanti-BrdUstaining.Thegraphshowsthepercentage(±SEM)ofBrdU+cells.SeealsoFigureS6.Cell140,477–490,February19,2010ª2010ElsevierInc.487translocatesintothenucleus.Merlindoesnotcontainaclassicalimportin-anuclearlocalizationsequencebuthasaC-terminalCRM1-dependentnuclearexportsignal(KresselandSchmucker,2002).MutationalanalysissuggeststhattheFERMdomainisnecessaryandsufﬁcientfornuclearentry,whereastheC-terminalcoiled-coildomaininhibitsthisprocessunlessitisfoldedbackandinteractswiththeFERMdomain.Inadditionorinstead,unfoldingoftheC-terminalhelicaldomainmayexposethenuclearexportsignalandtherebyfacilitateMerlin’sexitfromthenucleus.Interestingly,otherFERMdomainproteins,suchastheisoformsHandRofband4.1andFAK,appeartoshuttleinandoutofthenucleusthroughsimilarconformationaltransitions(Gascardetal.,1999;Limetal.,2008;Luqueetal.,1998).Uponenteringthenucleus,theclosedformofMerlinbindstotheC-terminalsegmentofDCAF1.OurresultsindicatethatMerlinisnotasubstrateofCRL4DCAF1butexertsitsantimito-genicfunctionbyblockingDCAF1-dependentrecruitmentorubiquitylationofCRL4DCAF1substrates.SincesubdomainAoftheFERMdomainofMerlinconsistsofanubiquitin-likefold(Shimizuetal.,2002),Merlinmayfunctionasaninhibitorypseu-dosubstrateforCRL4DCAF1.ReconstitutionofCRL4DCAF1ligaseactivityinvitrowillbenecessarytodirectlytestthismodel.Irre-spectiveofthespeciﬁcmechanismbywhichMerlininhibitsCRL4DCAF1,severallinesofevidencesupporttheconclusionthatthisinhibitoryinteractionrestrainscellproliferation.First,inactivationofMerlinenablesnormalcellstoexitfromcontactinhibitionandtoundergocellcycleprogression,whiledepletionofDCAF1suppressesbotheffects.Second,enforcedexpres-sionofaMerlin-insensitivemutantofDCAF1counteractstheantimitogeniceffectofMerlin.Third,depletionofDCAF1sup-presseshyperproliferationinMerlin-deﬁcientSchwannomaandmesotheliomacellsbutinhibitstheirnormalcounterparttoalesserextent,consistentwiththehypothesisthatlossofMerlinactivatesoncogenicsignalingthroughCRL4DCAF1.Finally,silencingofDCAF1suppressestheabilityofprimaryhumanSchwannomacellsfromNF2patientstoproliferateinvitro,sug-gestingthatderegulatedCRL4DCAF1activitycontributestothepathogenesisofNF2.CRL4ligaseshavebeenimplicatedinchromatinremodeling,DNAreplication,andtheresponsetoDNAdamage(LeeandZhou,2007;O’ConnellandHarper,2007).Forexample,CRL4DDB2promotestheubiquitylationofseveralhistonesandtheDNArepaircomponentsDDB2andXPC,restrictingthethresholdofDNAdamageresponseandinhibitingUV-inducedskincarcinogenesis,CRL4CSAmediatesubiquitylationofCSB,aSWI2/SNF2ATP-dependentchromatinremodelingenzyme,andCRL4DET1-Cop1promotesubiquitylationandproteasome-mediateddegradationofthetranscriptionfactorc-Jun(reviewedinLeeandZhou,2007andO’ConnellandHarper,2007;Liuetal.,2009).AlthoughthephysiologicalsubstratesofCRL4DCAF1havenotbeenidentiﬁed,ourresultssuggestthatCRL4DCAF1broadlyregulatesgeneexpression.Infact,expressionofMerlinanddepletionofDCAF1causesimilarchangesintheexpressionofseveralhundredgenes,suggestingthatMerlincontrolsawidegeneexpressionprogramthroughinhibitionofCRL4DCAF1.Notably,thisprogramincludestheinhibitionofgenesinvolvedinpromotingprogressionthrougheachphaseofthecellcycleaswellastheupregulationofgenesinvolvedingrowtharrestandapoptosis.Parenthetically,wespeculatethatknockdownofDCAF1maycauseanaccumulationofMerlin-deﬁcientcellsinG1becauselossofMerlinspeciﬁcallyderegulatesthisphaseofthecellcycle.Inaddition,wehaveobservedthatMerlincontrols,throughCRL4DCAF1,theexpressionofgenesinvolvedinreceptortyrosinekinaseandadhesionsignaling,intracellulartrafﬁcking,andasubsetofHippopathwaytargetgenes.TheabilityofCRL4DCAF1toregulatethesegenesmayexplainsomeoftheeffectsthatMerlinhasbeenreportedtoexertonreceptortyrosinekinaseandadhesionsignaling(Ammounetal.,2008;Curtoetal.,2007;Kissiletal.,2003;Lallemandetal.,2009;Okadaetal.,2005;Poulikakosetal.,2006;Shawetal.,2001).Theobservationthatre-expressionofMerlinanddepletionofDCAF1induceageneexpressionprogramofsimilarbreadth,speciﬁcity,andscopereinforcesthemodelthatMerlinsuppressestumorigenesisthroughinhibitionofCRL4DCAF1.Theanalysisoftumor-derivedmutations,inparticularmissensemutations,hasprovidedconsiderableinsightintothefunctionofimportanttumorsuppressors,suchasP53,RB,PTEN,andAPC.WehavestudiedsixpathogenicmissensemutationsmappingtotheFERMdomainofMerlinandfoundthateachofthemimpairstheabilityofMerlintoaccumulateinthenucleusand/orbindtoDCAF1.BothtypesofdefectsdisrupttheassociationofMerlinwithCRL4DCAF1.Incontrast,severetruncationmutants,suchas341X,displayincreasedaccumula-tioninthenucleusandinteractionwithCRL4DCAF1invivobutfailtosuppressligaseactivity.Amongthemissensemutations,L64R,F62S,andL64P,locatedinsubdomainA,disruptbindingtoDCAF1invitro,whereasL141PandA211D,mappingtosub-domainB,donot.Furthermore,E270G,whichremovesasinglechargefromthesurfaceofsubdomainC,drasticallyreducesbindingtoDCAF1invitro.TheseresultsimplicatesubdomainsAandCininteractionwithDCAF1andsuggestthatmutationsinotherportionsoftheprotein,suchassubdomainBandthehelicalsegment,mayaffectnuclearlocalizationdeterminantsordisrupttheclosedconformationthatisrequiredfornuclearaccumulation.TheobservationthatmanypathogenicNF2muta-tionsdisrupt,andseveralothersarepredictedtodisrupt,theabilityofMerlintointeractwithortosuppressCRL4DCAF1providesstronggeneticevidencethatMerlinsuppressestumor-igenesisbyinhibitingthisE3ligase.Inconclusion,ourresultsindicatethatNF2-dependenttumor-igenesisarisesfromtheinabilityofmutantMerlintoenterintothenucleusandtosuppressCRL4DCAF1-dependentgeneexpres-sion.Thisdelineatedtumor-suppressorpathwaybearsantitheticresemblancetotheWnt/b-cateninpathway,whereanintercel-lularsignalhijacksthecytoskeletalcomponentb-catenintopromoteoncogenicgeneexpressioninthenucleus(Clevers,2006).Identiﬁcationofthesubstrate(s)ofCRL4DCAF1andeluci-dationofthemechanismthroughwhichthisligaseexertsitspro-proliferativeandanti-apoptoticroleshouldhelptogeneratetargetedtherapiesforNF2mutanttumors.EXPERIMENTALPROCEDURESMaterialsandStandardProtocolsCells,antibodies,vectors,andothermaterialsaredescribedintheExtendedExperimentalProcedures.Theprotocolsusedforimmunoprecipitation,GST488Cell140,477–490,February19,2010ª2010ElsevierInc.pulldown,subcellularfractionation,andimmunoblottingareoutlinedintheExtendedExperimentalProcedures.TAPandMassSpectrometryCos7cellstransientlyexpressingFH-taggedMerlinorMerlin-L64PwerelysedinRIPAbufferandsubjectedtoTAPusingtheFLAGHATandemAfﬁnityPuriﬁcationKit(SigmaTP0010).ProteinswereseparatedbySDS-PAGE,visualizedwithGelcode(Pierce),andsubjectedtoMALDI-reTOF-MS/MS.Alternatively,gelstacksweresubjectedtonanoLC-MS/MS.SeedetailsintheExtendedExperimentalProcedures.ImmunoﬂuorescentStainingCellswereﬁxedwith4%paraformaldehydeinPBSfor20minandincubatedinpermeabilizationbuffer(PDT:0.3%sodiumdeoxycholateand0.3%TritonX-100inPBS)for30minonice.Fixationandpermeabilizationwithorganicsolvents,suchasmethanoloracetone,orﬁxationwithparaformaldehydefollowedbypermeabilizationwith0.5%TritonX-100alonefor20mindidnotallowefﬁcientdetectionofMerlininthenucleus.Afterﬁxationandpermeabi-lization,cellswereincubatedovernightat4CwithprimaryantibodiesdilutedinPDT.AfterwashingwithPDT,cellswereincubatedwithsecondaryanti-bodiesdilutedinPDTfor2hrat4C.CellswerewashedwithPDT,rinsedwithPBS,andmountedinGelvatol.Whenindicated,nucleiwerestainedwithDAPI.UbiquitylationAssayCos7cellsweretransfectedwithindicatedplasmidsand,whenindicated,treatedwith25mMMG132for6hr.Lysateswereincubatedwitheitheranti-FlagbeadsorcontrolmouseIgGbeads.Elutedproductsweresubjectedtoimmunoblotting.DetailedproceduresaredescribedintheExtendedExperi-mentalProcedures.BrdUIncorporationAssayCellsweresynchronizedinG0bygrowthfactordeprivationorgrowthtohighdensityandthenstimulatedwithmitogensfor24hrinthepresenceofBrdU.Anti-BrdUstainingwasusedtomeasureprogressionthroughG1andentryinSphase.SeedetailsintheExtendedExperimentalProcedures.GeneExpressionandSilencingRetroviralandlentiviralvectorsencodingrecombinantproteinsorshRNAsweregeneratedaspreviouslydescribed(Pylayevaetal.,2007).SequencesforshRNAsanddetailedproceduresaredescribedintheExtendedExperi-mentalProcedures.DNAMicroarrayAnalysisFC-1801cellswereleftuntreatedortransducedwithlentivirusesencodingsh-control,sh-DCAF1,Merlin-WT,Merlin-L64P,oracombinationofvirusesencodingsh-DCAF1andMerlin-WTandwereplatedintriplicateatsubconﬂu-entdensityincompletemedium.ComplementaryDNAs(cDNAs)werehybrid-izedtoGeneChipMouseGenome430a2.0Arraychips(Affymetrix).RawdataareavailableinGeneExpressionOmnibus(accessionnumberGSE19305).DataanalysisisdescribedintheExtendedExperimentalProcedures.SoftAgarandTumorigenicityAssayForsoftagarassay,cellsweretrypsinized,resuspendedincompletemedium,andplatedin0.34%lowmeltingtemperatureagarose(FMCBioproducts)incompletemedium.Meso-33cellswereseededat23104andFC-1801at63104perwellin6-wellUltraLowClusterPlates(Costar).Fortumorigenicityassay,23106FC-1801cellsweresuspendedincalcium/magnesium-freePBSandinjectedsubcutaneouslyintotherightﬂankofnudemice.Tumorvolumesweredeterminedbycalipermeasurement.ACCESSIONNUMBERSTheDNAmicroarraydatasetreportedinthispaperhasbeendepositedintheGeneExpressionOmnibusofNCBIwiththeaccessionnumberGSE19305.SUPPLEMENTALINFORMATIONSupplementalInformationincludesExtendedExperimentalProcedures,sixﬁgures,andonetableandcanbefoundwiththisarticleonlineatdoi:10.1016/j.cell.2010.01.029.ACKNOWLEDGMENTSWethankJ.Brugge,S.Jhanwar,andD.Limforcelllines,M.Paganoforconstructs,L.FabrizioandM.Yanevaforhelpwithmassspectrometry,andmembersoftheGiancottilaboratoryfordiscussions.ThisworkwassupportedbytheBakerStreetFoundationandNationalInstitutesofHealth(NIH)CancerCenterSupportGrantP30CA08748.W.L.isrecipientofaYoungInvestigatorAwardfromtheChildren’sTumorFoundation.P.Z.wassupportedbyNIHgrantR01CA098210.Received:January22,2009Revised:August7,2009Accepted:January16,2010Published:February18,2010REFERENCESAhronowitz,I.,Xin,W.,Kiely,R.,Sims,K.,MacCollin,M.,andNunes,F.P.(2007).MutationalspectrumoftheNF2gene:ameta-analysisof12yearsofresearchanddiagnosticlaboratoryﬁndings.Hum.Mutat.28,1–12.Ammoun,S.,Flaiz,C.,Ristic,N.,Schuldt,J.,andHanemann,C.O.(2008).Dissectingandtargetingthegrowthfactor-dependentandgrowthfactor-independentextracellularsignal-regulatedkinasepathwayinhumanschwannoma.CancerRes.68,5236–5245.Bretscher,A.,Edwards,K.,andFehon,R.G.(2002).ERMproteinsandmerlin:integratorsatthecellcortex.Nat.Rev.Mol.CellBiol.3,586–599.Cho,E.,Feng,Y.,Rauskolb,C.,Maitra,S.,Fehon,R.,andIrvine,K.D.(2006).DelineationofaFattumorsuppressorpathway.Nat.Genet.38,1142–1150.Clevers,H.(2006).Wnt/beta-cateninsignalingindevelopmentanddisease.Cell127,469–480.Curto,M.,Cole,B.K.,Lallemand,D.,Liu,C.H.,andMcClatchey,A.I.(2007).Contact-dependentinhibitionofEGFRsignalingbyNf2/Merlin.J.CellBiol.177,893–903.Gascard,P.,Nunomura,W.,Lee,G.,Walensky,L.D.,Krauss,S.W.,Takakuwa,Y.,Chasis,J.A.,Mohandas,N.,andConboy,J.G.(1999).Decipheringthenuclearimportpathwayforthecytoskeletalredcellprotein4.1R.Mol.Biol.Cell10,1783–1798.Gutmann,D.H.,Hirbe,A.C.,andHaipek,C.A.(2001).Functionalanalysisofneuroﬁbromatosis2(NF2)missensemutations.Hum.Mol.Genet.10,1519–1529.Hamaratoglu,F.,Willecke,M.,Kango-Singh,M.,Nolo,R.,Hyun,E.,Tao,C.,Jafar-Nejad,H.,andHalder,G.(2006).Thetumour-suppressorgenesNF2/MerlinandExpandedactthroughHipposignallingtoregulatecellproliferationandapoptosis.Nat.CellBiol.8,27–36.Hrecka,K.,Gierszewska,M.,Srivastava,S.,Kozaczkiewicz,L.,Swanson,S.K.,Florens,L.,Washburn,M.P.,andSkowronski,J.(2007).LentiviralVprusurpsCul4-DDB1[VprBP]E3ubiquitinligasetomodulatecellcycle.Proc.Natl.Acad.Sci.USA104,11778–11783.Huang,J.,andChen,J.(2008).VprBPtargetsMerlintotheRoc1-Cul4A-DDB1E3ligasecomplexfordegradation.Oncogene27,4056–4064.James,M.F.,Han,S.,Polizzano,C.,Plotkin,S.R.,Manning,B.D.,Stemmer-Rachamimov,A.O.,Gusella,J.F.,andRamesh,V.(2009).NF2/merlinisanovelnegativeregulatorofmTORcomplex1,andactivationofmTORC1isassociatedwithmeningiomaandschwannomagrowth.Mol.Cell.Biol.29,4250–4261.Jin,H.,Sperka,T.,Herrlich,P.,andMorrison,H.(2006a).TumorigenictransformationbyCPI-17throughinhibitionofamerlinphosphatase.Nature442,576–579.Cell140,477–490,February19,2010ª2010ElsevierInc.489Jin,J.,Arias,E.E.,Chen,J.,Harper,J.W.,andWalter,J.C.(2006b).AfamilyofdiverseCul4-Ddb1-interactingproteinsincludesCdt2,whichisrequiredforSphasedestructionofthereplicationfactorCdt1.Mol.Cell23,709–721.Kaempchen,K.,Mielke,K.,Utermark,T.,Langmesser,S.,andHanemann,C.O.(2003).UpregulationoftheRac1/JNKsignalingpathwayinprimaryhumanschwannomacells.Hum.Mol.Genet.12,1211–1221.Kissil,J.L.,Johnson,K.C.,Eckman,M.S.,andJacks,T.(2002).Merlinphos-phorylationbyp21-activatedkinase2andeffectsofphosphorylationonmerlinlocalization.J.Biol.Chem.277,10394–10399.Kissil,J.L.,Wilker,E.W.,Johnson,K.C.,Eckman,M.S.,Yaffe,M.B.,andJacks,T.(2003).Merlin,theproductoftheNf2tumorsuppressorgene,isaninhibitorofthep21-activatedkinase,Pak1.Mol.Cell12,841–849.Kressel,M.,andSchmucker,B.(2002).NucleocytoplasmictransferoftheNF2tumorsuppressorproteinmerlinisregulatedbyexon2andaCRM1-depen-dentnuclearexportsignalinexon15.Hum.Mol.Genet.11,2269–2278.Lallemand,D.,Curto,M.,Saotome,I.,Giovannini,M.,andMcClatchey,A.I.(2003).NF2deﬁciencypromotestumorigenesisandmetastasisbydestabiliz-ingadherensjunctions.GenesDev.17,1090–1100.Lallemand,D.,Manent,J.,Couvelard,A.,Watilliaux,A.,Siena,M.,Chareyre,F.,Lampin,A.,Niwa-Kawakita,M.,Kalamarides,M.,andGiovannini,M.(2009).MerlinregulatestransmembranereceptoraccumulationandsignalingattheplasmamembraneinprimarymouseSchwanncellsandinhumanschwannomas.Oncogene28,854–865.Lee,J.,andZhou,P.(2007).DCAFs,themissinglinkoftheCUL4-DDB1ubiquitinligase.Mol.Cell26,775–780.Lim,S.T.,Chen,X.L.,Lim,Y.,Hanson,D.A.,Vo,T.T.,Howerton,K.,Larocque,N.,Fisher,S.J.,Schlaepfer,D.D.,andIlic,D.(2008).NuclearFAKpromotescellproliferationandsurvivalthroughFERM-enhancedp53degradation.Mol.Cell29,9–22.Liu,L.,Lee,S.,Zhang,J.,Peters,S.B.,Hannah,J.,Zhang,Y.,Yin,Y.,Koff,A.,Ma,L.,andZhou,P.(2009).CUL4AabrogationaugmentsDNAdamageresponseandprotectionagainstskincarcinogenesis.Mol.Cell34,451–460.Lo´pez-Lago,M.A.,Okada,T.,Murillo,M.M.,Socci,N.,andGiancotti,F.G.(2009).LossofthetumorsuppressorgeneNF2,encodingmerlin,constitutivelyactivatesintegrin-dependentmTORC1signaling.Mol.Cell.Biol.29,4235–4249.Luque,C.M.,Lallena,M.J.,Alonso,M.A.,andCorreas,I.(1998).Analternativedomaindeterminesnuclearlocalizationinmultifunctionalprotein4.1.J.Biol.Chem.273,11643–11649.Maddika,S.,andChen,J.(2009).ProteinkinaseDYRK2isascaffoldthatfacilitatesassemblyofanE3ligase.Nat.CellBiol.11,409–419.McCall,C.M.,MilianideMarval,P.L.,Chastain,P.D.,2nd,Jackson,S.C.,He,Y.J.,Kotake,Y.,Cook,J.G.,andXiong,Y.(2008).Humanimmunodeﬁciencyvirustype1Vpr-bindingproteinVprBP,aWD40proteinassociatedwiththeDDB1-CUL4E3ubiquitinligase,isessentialforDNAreplicationandembryonicdevelopment.Mol.Cell.Biol.28,5621–5633.McClatchey,A.I.,andFehon,R.G.(2009).MerlinandtheERMproteins—regulatorsofreceptordistributionandsignalingatthecellcortex.TrendsCellBiol.19,198–206.McClatchey,A.I.,andGiovannini,M.(2005).Membraneorganizationandtumorigenesis—theNF2tumorsuppressor,Merlin.GenesDev.19,2265–2277.Muranen,T.,Gro¨nholm,M.,Renkema,G.H.,andCarpe´n,O.(2005).Cellcycle-dependentnucleocytoplasmicshuttlingoftheneuroﬁbromatosis2tumoursuppressormerlin.Oncogene24,1150–1158.O’Connell,B.C.,andHarper,J.W.(2007).Ubiquitinproteasomesystem(UPS):whatcanchromatindoforyou?Curr.Opin.CellBiol.19,206–214.Okada,T.,Lopez-Lago,M.,andGiancotti,F.G.(2005).Merlin/NF-2mediatescontactinhibitionofgrowthbysuppressingrecruitmentofRactotheplasmamembrane.J.CellBiol.171,361–371.Okada,T.,You,L.,andGiancotti,F.G.(2007).SheddinglightonMerlin’swizardry.TrendsCellBiol.17,222–229.Poulikakos,P.I.,Xiao,G.H.,Gallagher,R.,Jablonski,S.,Jhanwar,S.C.,andTesta,J.R.(2006).Re-expressionofthetumorsuppressorNF2/merlininhibitsinvasivenessinmesotheliomacellsandnegativelyregulatesFAK.Oncogene25,5960–5968.Pylayeva,Y.,Guo,W.,andGiancotti,F.G.(2007).Analysisofintegrinsignalingingeneticallyengineeredmousemodelsofmammarytumorprogression.MethodsEnzymol.426,439–461.Rong,R.,Tang,X.,Gutmann,D.H.,andYe,K.(2004).Neuroﬁbromatosis2(NF2)tumorsuppressormerlininhibitsphosphatidylinositol3-kinasethroughbindingtoPIKE-L.Proc.Natl.Acad.Sci.USA101,18200–18205.Schrecengost,R.S.,Riggins,R.B.,Thomas,K.S.,Guerrero,M.S.,andBouton,A.H.(2007).Breastcancerantiestrogenresistance-3expressionregulatesbreastcancercellmigrationthroughpromotionofp130Casmembranelocal-izationandmembranerufﬂing.CancerRes.67,6174–6182.Shaw,R.J.,Paez,J.G.,Curto,M.,Yaktine,A.,Pruitt,W.M.,Saotome,I.,O’Bryan,J.P.,Gupta,V.,Ratner,N.,Der,C.J.,etal.(2001).TheNf2tumorsuppressor,merlin,functionsinRac-dependentsignaling.Dev.Cell1,63–72.Shimizu,T.,Seto,A.,Maita,N.,Hamada,K.,Tsukita,S.,Tsukita,S.,andHakoshima,T.(2002).Structuralbasisforneuroﬁbromatosistype2.CrystalstructureofthemerlinFERMdomain.J.Biol.Chem.277,10332–10336.Tang,X.,Jang,S.W.,Wang,X.,Liu,Z.,Bahr,S.M.,Sun,S.Y.,Brat,D.,Gutmann,D.H.,andYe,K.(2007).Aktphosphorylationregulatesthetumour-suppressormerlinthroughubiquitinationanddegradation.Nat.CellBiol.9,1199–1207.Xiao,G.H.,Beeser,A.,Chernoff,J.,andTesta,J.R.(2002).p21-activatedkinaselinksRac/Cdc42signalingtomerlin.J.Biol.Chem.277,883–886.490Cell140,477–490,February19,2010ª2010ElsevierInc.